VEXOL 1% EYE DROPS

H02AB12(WHO)S01BA13(WHO) (8S,9S,10R,11S,13S,14S,16R,17S)-11-Hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one 49697-38-3Y 5311412 7099 DB00896Y 4470902N O7M2E4264D D05729Y ChEMBL1200617N DTXSID4045474 In​‍​​​​​‍​‍‍‍‍​‍‍teractive image CCC(=O)[C@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)C)C InChI=1S/C24H34O3/c1-6-20(27)24(5)14(2)11-18-17-8-7-15-12-16(25)9-10-22(15,3)21(17)19(26)13-23(18,24)4/h9-10,12,14,17-19,21,26H,6-8,11,13H2,1-5H3/t14-,17+,18+,19+,21-,22+,23+,24-/m1/s1NKey:QTTRZHGPGKRAFB-OOKHYKNYSA-NN Rimexoloneis aglucocorticoidsteroidused to treatinflammationin theeye.It is marketed as a 1%eye dropsuspension under the trade nameVexolbyAlcon Laboratories, but was discontinued in the US and other countries.